Application no. and date | 17725242.6 (espacenet) (Federated) (European Patent Register), 20170523 | Patent/reg. no. and date | DK/EP 3464288, 20201223 | Publication date | 20190410 | Priority no. and date | EP 16171538, 20160526, EP 16178891, 20160711 | EP pub. no. and date |
EP 3464288 20190410 | Effective date | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | Applicant ref. no. | 1550279 | Inventor | Ter Laak, Antonius, Hedwigstrasse 11
12159 Berlin, DE, BADER, Benjamin, Hillmannstrasse 14
13467 Berlin, DE, TEREBESI, Ildiko, Reichensteiner Weg 5
14195 Berlin, DE, WAGENFELD, Andrea, Weddingenweg 64
12205 Berlin, DE, SIEBENEICHER, Holger, Kruppstrasse 18
10557 Berlin, DE, NUBBEMEYER, Reinhard, Moorweg 96
13509 Berlin, DE, ROTTMANN, Antje, Schneehornpfad 11a
13089 Berlin, DE, IRLBACHER, Horst, Winsstrasse 47
10405 Berlin, DE, STEUBER, Holger, Hannoversche Strasse 19A
10115 Berlin, DE, KOPPITZ, Marcus, ElsenbruchstraÃYe 34A
13467 Berlin, DE, PETERS, Michaele, Heinrich-Roller Strasse 1
10405 Berlin, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/498 (2006.01) , A61P 15/00 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07D 487/08 (2006.01) | Title | [8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONER | Int. application no. | EP2017062359 | Int. publication no. | WO2017202817 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|